Original news and analysis on international IP policy
Infojustice writes: It was being reported among various observers of NAFTA over the weekend that the talks in the IP chapter are progressing toward Copyright. The US appears poised to table the first set of its demands for that portion of the IP chapter. But it is also rumored that that the US demand may exclude the issue of copyright balance.
The United States Supreme Court recently agreed to hear arguments in Oil States Energy Services v. Greene’s Energy Group, a case involving a patent on a device used for hydraulic fracturing (fracking). After the patent was granted, Greene’s petitioned for, and was granted, an “inter partes review (IPR)” by the US Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB). After losing at the board, Oil States asked the high court to determine that IPR, which is used to analyse the validity of existing patents, is unconstitutional because it takes away private property rights by denying Art. III jury trials.
This week, eLife and Collaborative Knowledge Foundation announced a partnership "to build a user-driven, open-source submission and peer-review platform" aimed at improving on existing industry models.
NEW YORK -- The music community in the United States has a wide copyright agenda covering various business issues and stakeholders. While it had entertained the notion that a new President with its new administration and Congress would be more sympathetic to the complex needs of the industry, it is still waiting for the Trump administration to act on copyright issues, judging from comments made by various stakeholders in the legislative process during an industry panel in New York this week.
WASHINGTON, DC -- The still-emerging breakthrough CRISPR gene editing tool has the potential to transform the field and do enormous good for humankind. But let’s make sure we understand it better and ensure the public interest before launching into using it too widely. Meanwhile, companies and researchers are actively licensing the technology. That was a message of a set of panellists working close to CRISPR’s development, speaking at a recent event in Washington, DC.
The Office of the United States Trade Representative (USTR) today announced an "out-of-cycle" review of Thailand's intellectual property policies after what USTR said were reports of improvement on several IP issues including trademarks and enforcement. Another area of the review will be pharmaceuticals.
"There are clear opportunities to accelerate and expand opportunity through innovation and technology around the world," finds a new report from the Washington, DC-based Center for Strategic and International Studies (CSIS). And the United States - and any other developed country - would do well to position itself as a "partner of choice for developing countries that want to transform their economies through science, technology and innovation," it said. But strong intellectual property rights and a business-friendly environment are a necessity, it argues.
Heading into the final stretch of the year, it is a good time to catch up on all of the staff changes that have occurred in governments, industry, law firms and nongovernmental organisations related to the IP community in Geneva. Here is a rundown of some of top moves made by people since the start of the year.
Ministers from Mexico, Canada and the United States concluded the second weeklong round of negotiations for an updated North American Free Trade Agreement in the past four weeks, and claimed progress on "important" issues and the shaping of a text with some 24 chapters. But the government officials offered no specifics to the public.
Experts at a one-day workshop in Washington DC next week will discuss public interest aspects of patents and two breakthrough new medical technologies related to gene editing (CRISPR) and cancer treatment (CAR T).